SpyGlass DS-Directed Radiofrequency Ablation With Double Biliary Metal Stent Placement for Managing Recurrent Obstructive Jaundice Secondary to Castleman Disease: A Case Report of a Rare Disease.

Yongjin Chen, Chang Fu, Junhong Chen, Weicong Pan, Yu Fu, Kai Liu

Abstract readCase Reports

In one paragraph

Article in Frontiers in surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yongjin ChenDepartment of Hepatopancreatobiliary Surgery, The First Hospital of Jilin University, Changchun, China.

Chang FuDepartment of Hepatopancreatobiliary Surgery, The First Hospital of Jilin University, Changchun, China.

Junhong ChenDepartment of Hepatopancreatobiliary Surgery, The First Hospital of Jilin University, Changchun, China.

Weicong PanDepartment of Hepatopancreatobiliary Surgery, The First Hospital of Jilin University, Changchun, China.

Yu FuDepartment of Hepatopancreatobiliary Surgery, The First Hospital of Jilin University, Changchun, China.

Kai LiuDepartment of Hepatopancreatobiliary Surgery, The First Hospital of Jilin University, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Castleman disease (CD) rarely presents with obstructive jaundice, which poses a diagnostic and therapeutic challenge to the management of the disease. A 40-year-old man was referred to our hospital for emergent management of upper abdominal pain. An abdominal mass was removed, and the postoperative pathology showed retroperitoneum CD, which was subsequently managed by adjuvant therapy of combination chemotherapy and steroids. One month later, a biliary metal stent was placed due to the presentation of obstructive jaundice. After ~3 months, the patient experienced another episode of obstructive jaundice, and SpyGlass DS cholangioscopy was performed

Indexed as

biliary tractCastleman diseasecholangioscopyobstructive jaundiceradiofrequency ablationSpyGlass DS

Identifiers

PMID35310448

DOI10.3389/fsurg.2022.800050

PMCPMC8924354

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.